We are live on ! Find out more
AGA

Altrinsic Global Advisors Portfolio holdings

AUM $2.79B
1-Year Est. Return 7.25%
This Fund
S&P 500
This Quarter Est. Return
-0.87%
1 Year Est. Return
+7.25%
3 Year Est. Return
+44.27%
5 Year Est. Return
+55.25%
10 Year Est. Return
+173.46%
AUM
$2.7B
AUM Growth
-$37.5M
Cap. Flow
+$15.5M
Cap. Flow %
0.57%
Top 10 Hldgs %
48.7%
Holding
85
New
5
Increased
24
Reduced
40
Closed
3

Top Sells

Rank Stock Value
1
AON icon
Aon
AON
+$31M
2
CYH icon
Community Health Systems
CYH
+$27.3M
3
WBD icon
Warner Bros
WBD
+$27.1M
4
PYPL icon
PayPal
PYPL
+$16.6M
5
EBAY icon
eBay
EBAY
+$16.4M

Sector Composition

Rank Sector Weight
1 Financials 35.63%
2 Communication Services 20.4%
3 Healthcare 11.18%
4 Energy 7.11%
5 Industrials 6.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NSTG
51
DELISTED
NanoString Technologies, Inc.
NSTG
$4.97M 0.18%
223,111
-20,000
-8% -$429K
CBPO
52
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$4.5M 0.17%
41,858
SNDA icon
53
Sonida Senior Living
SNDA
$2.03B
$4.43M 0.16%
18,400
RAD
54
DELISTED
Rite Aid Corporation
RAD
$4.26M 0.16%
25,875
BKD icon
55
Brookdale Senior Living
BKD
$3.62B
$4.25M 0.16%
342,452
KND
56
DELISTED
Kindred Healthcare
KND
$4.21M 0.16%
537,000
+50,000
+10% +$410K
NVDQ
57
DELISTED
Novadaq Technologies Inc.
NVDQ
$4.19M 0.16%
591,100
+120,000
+25% +$1.09M
BMRN icon
58
BioMarin Pharmaceuticals
BMRN
$12B
$4.16M 0.15%
50,168
-20,000
-29% -$1.72M
DVCR
59
DELISTED
Diversicare Healthcare Services Inc
DVCR
$4.09M 0.15%
393,266
-50,686
-11% -$583K
ALNY icon
60
Alnylam Pharmaceuticals
ALNY
$38.2B
$3.85M 0.14%
102,700
+30,000
+41% +$1.26M
ELGX
61
DELISTED
Endologix Inc
ELGX
$3.83M 0.14%
67,000
+11,000
+20% +$1.01M
SPNE
62
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$3.41M 0.13%
431,340
+20,000
+5% +$169K
TSM icon
63
TSMC
TSM
$2.03T
$2.2M 0.08%
76,516
+13,459
+21% +$405K
PRGO icon
64
Perrigo
PRGO
$1.43B
$2.08M 0.08%
25,000
VIV icon
65
Telefônica Brasil
VIV
$21B
$2.08M 0.08%
155,502
+90,350
+139% +$1.21M
AGTC
66
DELISTED
Applied Genetic Technologies Corporation
AGTC
$2.05M 0.08%
219,000
BABA icon
67
Alibaba
BABA
$277B
$2.03M 0.08%
23,148
+1,692
+8% +$163K
SGMO
68
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1.92M 0.07%
630,000
CFMS
69
DELISTED
Conformis, Inc. Common Stock
CFMS
$1.85M 0.07%
9,158
JD icon
70
JD.com
JD
$42.9B
$1.73M 0.06%
67,799
+18,431
+37% +$480K
NBIS
71
Nebius Group N.V.
NBIS
$43.2B
$1.65M 0.06%
81,754
+31,348
+62% +$617K
TEAR
72
DELISTED
TearLab Corporation
TEAR
$1.58M 0.06%
303,510
VYGR icon
73
Voyager Therapeutics
VYGR
$181M
$1.27M 0.05%
+100,000
New +$1.28M
CHU
74
DELISTED
China Unicom (HONG KONG) Limited
CHU
$1.11M 0.04%
96,047
+38,332
+66% +$452K
PRQR icon
75
ProQR Therapeutics
PRQR
$244M
$1.03M 0.04%
210,556

Similar funds

Altrinsic Global Advisors's Q4 2016 Portfolio in Review

As of Q4 2016, Altrinsic Global Advisors held 85 positions worth $2.7B, down 1.4% from $2.73B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Altrinsic Global Advisors's Q4 2016 filing shows 5 new, 24 increased, 40 reduced and 3 closed positions. Its largest new stake was Willis Towers Watson: 1,428,414 shares worth $175M. The largest sale was Aon, an estimated $31M.

By sector, the portfolio is most concentrated in Financials at 36% of assets, up from 31% a quarter earlier, followed by Communication Services and Healthcare.

  • Altrinsic Global Advisors's largest Q4 2016 buy was Willis Towers Watson: 1,428,414 shares worth $175M.
  • Altrinsic Global Advisors added most to Televisa in Q4 2016, an estimated $27M increase.
  • Altrinsic Global Advisors's biggest Q4 2016 reduction was Aon, cutting an estimated $31M.
  • Altrinsic Global Advisors fully exited Community Health Systems in Q4 2016, selling an estimated $27.3M.
  • Altrinsic Global Advisors's ten largest holdings make up 49% of its $2.7B portfolio in Q4 2016.
  • Altrinsic Global Advisors opened 5 new positions and closed 3 in Q4 2016.
  • Altrinsic Global Advisors's portfolio value fell 1.4% quarter-over-quarter to $2.7B.

Based on Altrinsic Global Advisors's 13F filing for Q4 2016, filed 13 Feb 2017.